Medications for Hodgkin Disease

22 results

  • Acacia (acacia)

    (Acacia)
    Nelco Laboratories, Inc.
    Usage: Allergenic extracts are used for diagnostic testing and treatment of allergic diseases. They are indicated for hyposensitization or immunotherapy when avoidance of allergens isn't feasible. They may supplement pharmacotherapy and should be administered based on specific allergens relevant to the patient's history and exposure.

  • Acacia (acacia)

    (Acacia)
    Nelco Laboratories, Inc.
    Usage: Allergenic extracts are indicated for diagnostic testing and treatment of allergic diseases, specifically for hyposensitization or immunotherapy when avoiding allergens is not possible. They may be used alongside other medications and should only target specific allergens the patient is allergic to.

  • Aminocaproic acid (aminocaproic acid)

    (Aminocaproic Acid)
    Optimus Pharma Private Limited
    Usage: Aminocaproic acid tablets enhance hemostasis in bleeding due to fibrinolysis, particularly in surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. They also address excessive urinary tract fibrinolytic bleeding post-surgery or due to genitourinary diseases. Emergency measures may be needed in severe cases.

  • Bleomycin (bleomycin sulfate)

    (BLEOMYCIN SULFATE)
    Fresenius Kabi USA, LLC
    Usage: Bleomycin for Injection, USP is indicated for palliative treatment of various neoplasms, including squamous cell carcinoma (head and neck, penis, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), and testicular carcinoma (embryonal cell, choriocarcinoma, teratocarcinoma). It also helps manage malignant pleural effusion.

  • Bleomycin (bleomycin)

    (BLEOMYCIN)
    Hospira, Inc.
    Usage: Bleomycin for Injection is a palliative treatment indicated for various neoplasms, including squamous cell carcinoma (head and neck, cervix, vulva), lymphomas (Hodgkin's and non-Hodgkin's), testicular carcinoma (embryonal cell, choriocarcinoma), and for managing malignant pleural effusions as a sclerosing agent.

  • Carmustine (carmustine)

    (CARMUSTINE)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Usage: Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

  • Carmustine (carmustine)

    (CARMUSTINE)
    Sandoz Inc.
    Usage: Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

  • Carmustine (carmustine)

    (CARMUSTINE)
    Accord Healthcare Inc.
    Usage: Carmustine for Injection is indicated for palliative therapy in brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (in combination with other approved drugs).

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, and certain solid tumors. It is also used for pediatric patients with biopsy-proven minimal change nephrotic syndrome who have not responded to corticosteroid therapy. Safety in adults for nephrotic syndrome is unestablished.

  • Cyclophosphamide (cyclophosphamide)

    (cyclophosphamide)
    Bamboo US BidCo LLC
    Usage: Cyclophosphamide is indicated for treating various malignant diseases including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy is ineffective or intolerable.